PTC THERAPEUTICS, INC. (PTCT) Operating Income (Loss) USD 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ptc Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2024.
  • Ptc Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$45.5 M, a 61.4% increase year-over-year.
  • Ptc Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$367 M, a 23.2% increase year-over-year.
  • Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$440 M, a 1.77% increase from 2022.
  • Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$447 M, a 19.5% decline from 2021.
  • Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$374 M, a 13.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$367 M -$45.5 M +$72.2 M +61.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$440 M $5.82 M +$206 M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$646 M -$118 M -$50 M -73.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 -$596 M -$210 M -$117 M -127% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$479 M -$118 M -$31.1 M -35.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$447 M -$200 M -$116 M -136% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$332 M -$68.2 M +$24.9 M +26.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$357 M -$92.4 M +$6.13 M +6.23% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$363 M -$86.5 M +$11.6 M +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 -$374 M -$84.7 M +$11.6 M +12.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$386 M -$93.1 M -$37.9 M -68.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 -$348 M -$98.5 M +$88.8 M +47.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$437 M -$98.1 M -$5.16 M -5.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$432 M -$96.4 M -$23.6 M -32.4% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$408 M -$55.1 M +$5.34 M +8.84% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$414 M -$187 M -$149 M -383% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$265 M -$93 M -$23.9 M -34.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$241 M -$72.8 M -$27.6 M -61.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$214 M -$60.5 M -$12.2 M -25.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$201 M -$38.8 M -$33.2 M -595% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$168 M -$69.1 M -$52.4 M -313% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$116 M -$45.1 M -$50.6 M -928% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$65.1 M -$48.2 M -$17.3 M -56.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$47.8 M -$5.57 M +$6.92 M +55.4% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$54.7 M -$16.7 M +$9.61 M +36.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$64.3 M $5.45 M +$30.4 M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$94.7 M -$30.9 M +$1.17 M +3.66% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$95.9 M -$12.5 M +$24.1 M +65.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$120 M -$26.4 M +$12.1 M +31.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$132 M -$25 M +$23.2 M +48.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$155 M -$32.1 M +$10.2 M +24.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$165 M -$36.6 M +$2.07 M +5.35% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$168 M -$38.4 M -$371 K -0.97% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$167 M -$48.2 M -$16 M -49.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$151 M -$42.2 M -$14.6 M -53% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$137 M -$38.6 M -$13.3 M -52.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$123 M -$38.1 M -$23.9 M -168% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$99.4 M -$32.2 M -$14.1 M -78.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$85.3 M -$27.6 M -$23.3 M -545% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$62 M -$25.4 M -$10.9 M -75.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$51 M -$14.2 M -$5.64 M -65.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$45.4 M -$18.1 M -$12.1 M -200% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 -$33.3 M -$4.28 M +$2.78 M +39.4% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 -$36.1 M -$14.5 M -$6.95 M -92.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 -$29.2 M -$8.58 M -$2.36 M -37.9% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 -$26.8 M -$6.03 M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 -$7.06 M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-06
Q2 2012 -$7.5 M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-06
Q1 2012 -$6.22 M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.